Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1800895
PUBLISHER: IMARC | PRODUCT CODE: 1800895
Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033
PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global osteoarthritis therapeutics market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.3 Billion by 2033, exhibiting a growth rate (CAGR) of 6.82% during 2025-2033.
Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.
Global Osteoarthritis Therapeutics Market Trends and Drivers:
Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.
Key Market Segmentation:
Breakup by Anatomy Type:
- Knee
- Hip
- Hand
- Spine
- Others
Breakup by Drug Type:
- Nonsteroidal Anti-Inflammatory Drugs
- Analgesics
- Corticosteroids
- Others
Breakup by Route of Administration:
- Parenteral
- Topical
- Oral
Breakup by Distribution Channel:
- Hospitals
- Specialty Clinics
- Medical Institutions
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.
Key Questions Answered in This Report
- 1.What was the size of the global osteoarthritis therapeutics market in 2024?
- 2.What is the expected growth rate of the global osteoarthritis therapeutics market during 2025-2033?
- 3.What are the key factors driving the global osteoarthritis therapeutics market?
- 4.What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
- 5.What is the breakup of the global osteoarthritis therapeutics market based on the anatomy type?
- 6.What is the breakup of the global osteoarthritis therapeutics market based on the drug type?
- 7.What is the breakup of the global osteoarthritis therapeutics market based on the route of administration?
- 8.What is the breakup of the global osteoarthritis therapeutics market based on the distribution channel?
- 9.What are the key regions in the global osteoarthritis therapeutics market?
- 10.Who are the key players/companies in the global osteoarthritis therapeutics market?
Product Code: SR112025A2791
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Osteoarthritis Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Anatomy Type
- 6.1 Knee
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Hip
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Hand
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Spine
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Nonsteroidal Anti-Inflammatory Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Analgesics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Corticosteroids
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Parenteral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Topical
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Oral
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Specialty Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Medical Institutions
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Anika Therapeutics Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Bayer Aktiengesellschaft
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Eli Lilly and Company
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Flexion Therapeutics Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 GlaxoSmithKline Plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Horizon Therapeutics Plc
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Johnson & Johnson Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Pfizer Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
Product Code: SR112025A2791
List of Figures
- Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2024
- Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2024
- Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2024
- Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2024
- Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
- Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
- Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million USD), 2025-2033
- Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
- Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
- Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Osteoarthritis Therapeutics Market: Competitive Structure
- Table 8: Global: Osteoarthritis Therapeutics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.